Physical growth, puberty and hormones in adolescents with Nodding Syndrome; a pilot study

Simple item page
dc.contributor.authorPiloya-Were, Theresa
dc.contributor.authorOdongkara-Mpora, Beatrice
dc.contributor.authorNamusoke, Hanifa
dc.contributor.authorIdro, Richard
dc.date.accessioned2023-02-12T20:49:34Z
dc.date.available2023-02-12T20:49:34Z
dc.date.issued2014
dc.description.abstractNodding syndrome is an epidemic symptomatic generalized epilepsy syndrome of unknown cause in Eastern Africa. Some patients have extreme short stature. We hypothesized that growth failure in nodding syndrome is associated with specific endocrine dysfunctions. In this pilot study, we examined the relationship between serum hormone levels and stature, bone age and sexual development. Results: We recruited ten consecutive children, 13 years or older, with World Health Organization defined nodding syndrome and assessed physical growth, bone age, development of secondary sexual characteristics and serum hormone levels. Two children with incomplete results were excluded. Of the eight remaining, two had severe stunting (height for age Z [HAZ] score < -3) and three had moderate stunting (HAZ score between-3 and -2). The bone age was delayed by a median 3(range 0-4) years. Serum growth hormone levels were normal in all eight but the two patients with severe stunting and one with moderate stunting had low levels of Somatomedin C (Insulin like Growth Factor [IGF1]) and/or IGF binding protein 3 (IGFBP3), mediators of growth hormone function. A linear relationship was observed between serum IGF1 level and HAZ score. With the exception of one child, all were either pre-pubertal or in early puberty (Tanner stages 1 and 2) and in the seven, levels of the gonadotrophins (luteinising and follicle stimulating hormone) and the sex hormones (testosterone/oestrogen) were all within pre-pubertal ranges or ranges of early puberty. Thyroid function, prolactin, adrenal, and parathyroid hormone levels were all normal. Conclusions: Patients with nodding syndrome may have dysfunctions in the pituitary growth hormone and pituitary gonadal axes that manifest as stunted growth, delayed bone age and puberty. Studies are required to determine if such endocrine dysfunction is a primary manifestation of the disease or a secondary consequence of chronic ill health and malnutrition and if so, whether targeted interventions can improve outcome.en_US
dc.identifier.citationPiloya-Were, T., Odongkara-Mpora, B., Namusoke, H., & Idro, R. (2014). Physical growth, puberty and hormones in adolescents with Nodding Syndrome; a pilot study. BMC Research Notes, 7, 1-5. doi:10.1186/1756-0500-7-858en_US
dc.identifier.other10.1186/1756-0500-7-858
dc.identifier.urihttps://nru.uncst.go.ug/handle/123456789/7776
dc.language.isoenen_US
dc.publisherBMC Research Notesen_US
dc.subjectNodding syndromeen_US
dc.subjectEpilepsyen_US
dc.subjectGrowthen_US
dc.subjectPubertyen_US
dc.subjectHormonesen_US
dc.titlePhysical growth, puberty and hormones in adolescents with Nodding Syndrome; a pilot studyen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Physical growth, puberty and hormones in.pdf
Size:
282.15 KB
Format:
Adobe Portable Document Format
Description:
Article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Medical and Health Sciences